In an above‑knee amputee with severe spasticity unresponsive to oral baclofen, what management options should be considered?

Management of Severe Spasms in Above-Knee Amputee Unresponsive to Oral Baclofen

When oral baclofen fails to control severe spasms in an above-knee amputee, you should trial tizanidine as the next oral agent, and if oral medications remain ineffective or poorly tolerated, proceed to botulinum toxin injections for focal spasticity or consider intrathecal baclofen for severe generalized spasticity.

Stepwise Approach to Refractory Spasticity

First-Line Adjustments

Before abandoning oral baclofen entirely, verify the patient is on an adequate dose. Older adults rarely tolerate doses greater than 30-40 mg per day 1, but younger amputees may benefit from higher doses if tolerated. Monitor for muscle weakness, urinary dysfunction, cognitive effects, and sedation 1.

Alternative Oral Agents

If baclofen is ineffective or not tolerated:

• Tizanidine (Zanaflex): Start at 2 mg up to three times daily 1. This agent has shown efficacy in chronic patients with improvement in spasticity and pain without loss of motor strength [@2,@3,@4,@6,2]. Monitor for muscle weakness, urinary function, cognitive effects, sedation, and orthostasis. Be aware of potential drug-drug interactions 1.

• Dantrolene: Consider if tizanidine fails, though it has limited trial data and the benefit is primarily no cognitive side effects [@2,@3,@4,@6,@7,2].

• Avoid benzodiazepines (including clonazepam and diazepam) as they can cause significant sedation and may have deleterious effects, particularly in stroke recovery contexts [@2,@3,@4,@6,2].

Focal Injectable Therapies

For localized severe spasms, botulinum toxin injections are highly effective [@5,3]:

• Class I recommendation for reducing spasticity, improving range of motion, and addressing pain [@5,3]
• Target specific muscle groups causing the most problematic spasms
• All FDA-approved formulations (onaBoNT-A, aboBoNT-A, incoBoNT-A) are effective [@12@]
• Effects last 3-4 months, requiring repeat injections
• Can be combined with continued oral agents if needed

Intrathecal Baclofen (ITB)

For severe generalized spasticity unresponsive to oral medications, intrathecal baclofen is the definitive next step [@2,@3,@4,@5,@6,@7,@8,3]:

• Delivers baclofen directly to cerebrospinal fluid at 1/100th the oral dose 4
• Class IIb recommendation for severe spastic hypertonia not responding to other interventions [@5,3]
• Can be considered as early as 3-6 months after injury for patients refractory to other treatments [@5,3]
• Requires screening test dose (typically 50 μg, though 42% of patients need this dose and 34% require over 100 μg) 5
• Effective maintenance doses average 360 μg per day 5, with typical ranges of 365-650 μg/day 6
• Requires pump refills every 2-3 months and pump replacement every 6-7 years 7
• Complications occur in approximately 25% (infection, skin perforation, catheter issues, pump malfunction), but 85% can continue therapy after revision 5

Physical Modalities as Adjuncts

Throughout this escalation, maintain:

• Positioning and range of motion exercises several times daily [@2,@3,@4,@6,2]
• Stretching programs
• Consider splinting or serial casting if contractures develop [@2,@3,@4,@6,2]
• Neuromuscular electrical stimulation may provide temporary benefit as adjunct to therapy [@5,3]

Critical Pitfalls to Avoid

1. Don't assume baclofen failure means all oral agents will fail - tizanidine has a different mechanism and may work when baclofen doesn't [@2,@3,@4,@6,2]

2. Don't use benzodiazepines as next-line therapy despite their antispasmodic properties - sedation and other side effects outweigh benefits [@2,@3,@4,@6,2]

3. Don't delay ITB consideration in truly refractory cases - waiting too long allows contractures to develop, which are less reversible [@2,@3,@4,@6,@7,2]

4. Recognize that spasticity in amputees differs from stroke - the FDA label specifically states baclofen efficacy "has not been established" in stroke 8, but it IS indicated for spinal cord injuries and diseases 8, making it appropriate for traumatic amputations with spinal involvement

5. Screen for and treat trigger factors - infection, skin breakdown, or other noxious stimuli can dramatically worsen spasticity 9, 10

Algorithm Summary

1. Optimize oral baclofen dose (if not already done)
2. Switch to tizanidine if baclofen ineffective/intolerable
3. Add botulinum toxin for focal problematic muscle groups
4. Consider intrathecal baclofen if generalized severe spasticity persists despite above measures
5. Maintain physical therapy throughout all stages

The choice between botulinum toxin and ITB depends on whether spasticity is focal (favoring botulinum) or generalized (favoring ITB), and on patient preferences regarding invasiveness versus frequency of interventions [@5,@10,